Project 1: Immune correlates of cCMV
项目 1:cCMV 的免疫相关因素
基本信息
- 批准号:10215784
- 负责人:
- 金额:$ 0.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-24 至 2020-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAdverse effectsAntibodiesAntibody ResponseAutomobile DrivingB-LymphocytesBirthBloodCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCytomegalovirusCytomegalovirus InfectionsCytomegalovirus VaccinesCytotoxic T-LymphocytesDevelopmentDiseaseEpilepsyEpithelialEpitheliumEvaluationFaceFemaleFetal DiseasesFetusFutureGlobulinsHumanImmuneImmune TargetingImmune responseImmune systemImmunityImmunocompetentImmunological ModelsImmunologicsImpaired cognitionIndividualInfantInfusion proceduresKineticsLengthLymphocyteMS4A1 geneMacacaMacaca mulattaMeasuresModelingMothersNatural ImmunityNeurologicOutcomePartner in relationshipPathologyPlacentaPlasmaPopulationPregnancyPregnancy OutcomePrimary InfectionRhesusRiskRoleT cell responseT memory cellT-Cell DepletionT-LymphocyteTacrolimus Binding ProteinsTestingVaccinatedVaccinesVariantViralViremiaVirusarmcongenital cytomegaloviruscongenital infectiondeep sequencingdesigndisabilityexhaustionexperimental studyfetalfetal lossgenetic analysisgenetic manipulationhearing impairmentin vivoinsightmotor impairmentneutralizing antibodynonhuman primatenovelpregnantpressurepreventprogramsresponseseropositivetransmission processviral transmissionvirologyvirus genetics
项目摘要
Abstract – Project 1: Immune correlates of protection against congenital CMV
Cytomegalovirus is the most common congenital infection, complicating 40,000 births in the U.S. annually. Up
to 25% of infants born with CMV will have permanent neurologic disabilities, including hearing loss.
Development of a maternal vaccine that induces effective preconception immunity offers the best hope of
eliminating congenital CMV (cCMV), yet this strategy faces significant hurdles. Among these are the
incomplete protection conferred by natural immunity and an incomplete understanding of what constitutes
protective CMV immunity. While CMV-seropositive mothers have a reduced risk of vertical CMV transmission
upon reinfection compared to CMV-naïve mothers with primary infection during pregnancy, they can still
transmit virus. Because natural immunity is only partially protective, an effective vaccine will need to induce
a more robust or modified preconception immune response. To investigate immune protection against
cCMV, we established a novel nonhuman primate (NHP) model of placental cCMV transmission in rhesus
monkeys, and showed that maternal CD4+ T cell responses are critical in protection. A lag in the development
of CMV-neutralizing antibodies and cytotoxic T lymphocytes was associated with a more severe outcome; and
passive infusion of CMV seronegative dams with hyperimmune globulin prior to rhesus CMV inoculation
protected against fetal loss. Although these studies highlight the importance of maternal immunity, the
contribution of individual arms of the immune system in preventing cCMV remains unclear. Project 1 will
therefore test the hypothesis that both humoral and cellular maternal CMV-specific immune responses are
required to prevent cCMV infection. Defining the precise contribution of individual components of anti-CMV
immunity to (i) inhibition of placental transmission and (ii) modulation of fetal disease is necessary to determine
whether CMV vaccines should target one or both arms of the adaptive immune system. In concert with Cores
1-4, Project 1 will use a combination of genetic analysis, in vivo depletion experiments, and exhaustive
immune and virologic evaluation to characterize transmitted virus variants and determine the contribution of
CMV-specific humoral and cellular immune responses in protecting against cCMV in the NHP model. Our
specific aims are as follows: Aim 1: Characterize placental CMV transmission during primary infection in
immunocompetent dams and define maternal and fetal immune correlates of protection against transmission;
Aim 2: Determine the contribution of B and CD8+ T cell immunity to protection against placental CMV
transmission; Aim 3: Determine whether vaccine-induced pre-conception T cell immunity is sufficient to lower
plasma viremia and protect against placental CMV transmission or fetal loss in primary infection. These studies
will provide insight in to the correlates of immune protection against placental CMV transmission in a highly
relevant model of cCMV infection and inform the immunologic targets of an effective CMV vaccine.
项目1:预防先天性巨细胞病毒的免疫相关因素
巨细胞病毒是最常见的先天性感染,在美国每年导致4万名新生儿并发。向上
出生时患有巨细胞病毒的婴儿中有25%会有永久性的神经残疾,包括听力损失。
开发一种诱导有效先天免疫的母体疫苗提供了最大的希望
消除先天性巨细胞病毒(CCMV),但这一战略面临重大障碍。其中包括
自然豁免权给予的不完全保护和对构成因素的不完全理解
保护性巨细胞病毒免疫。而CMV血清阳性的母亲垂直传播CMV的风险较低
在再次感染时,与初次感染巨细胞病毒的母亲相比,她们仍然可以
传播病毒。由于自然免疫只能起到部分保护作用,因此一种有效的疫苗需要诱导
一种更强健的或修改过的先入为主的免疫反应。研究针对病毒的免疫保护
CCMV,我们建立了一种新的恒河猴胎盘CCMV传播模型
并表明母体的CD4+T细胞反应在保护中是至关重要的。发展中的滞后
巨细胞病毒中和抗体和细胞毒性T淋巴细胞与更严重的结局相关;
在恒河猴接种巨细胞病毒前用高免球蛋白被动输注巨细胞病毒血清阴性鼠
保护胎儿不会丢失。尽管这些研究强调了母体免疫的重要性,但
免疫系统的各个分支在预防CCMV中的作用尚不清楚。项目1将
因此,验证体液和细胞性母体CMV特异性免疫反应都是
预防CCMV感染所需的。确定抗CMV单项成分的确切作用
免疫(I)抑制胎盘传播和(Ii)调节胎儿疾病是必要的,以确定
巨细胞病毒疫苗是否应该针对适应性免疫系统的一只或两只手臂。与岩心协调一致
1-4,项目1将结合使用遗传分析、体内耗尽实验和穷举法
免疫学和病毒学评估以确定传播的病毒变体的特征并确定
在NHP模型中,CMV特异性体液和细胞免疫反应在预防CCMV中的作用。我们的
具体目标如下:目标1:研究人胎盘巨细胞病毒在初次感染过程中的传播特征
建立具有免疫活性的母体,并确定预防传播的母婴免疫相关因素;
目的2:确定B和CD8+T细胞免疫在胎盘CMV免疫保护中的作用
传播;目标3:确定疫苗诱导的受孕前T细胞免疫是否足以降低
血浆病毒血症和预防原发感染时胎盘巨细胞病毒传播或胎儿丢失。这些研究
将提供对胎盘CMV传播的免疫保护的相关性的洞察
CCMV感染的相关模型,并为有效的CMV疫苗的免疫学指标提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sallie R. Permar其他文献
Neonatal Cytomegalovirus Infection: Advocacy, Legislation, and Changing Practice
新生儿巨细胞病毒感染:倡导、立法和实践的改变
- DOI:
10.1016/j.clp.2024.10.008 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:2.400
- 作者:
Ashley Stark;Chelsea M. Crooks;Sallie R. Permar;Kristin Elizabeth Dew Weimer - 通讯作者:
Kristin Elizabeth Dew Weimer
Maternal immune protection against infectious diseases
针对传染病的母体免疫保护
- DOI:
10.1016/j.chom.2022.04.007 - 发表时间:
2022-05-11 - 期刊:
- 影响因子:18.700
- 作者:
Stephanie N. Langel;Maria Blasi;Sallie R. Permar - 通讯作者:
Sallie R. Permar
Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus
工程化二聚体免疫球蛋白 A 的母乳递送可保护新生儿免受轮状病毒感染
- DOI:
10.1016/j.mucimm.2025.01.002 - 发表时间:
2025-04-01 - 期刊:
- 影响因子:7.600
- 作者:
Stephanie N. Langel;Claire E. Otero;Justin T. Steppe;Caitlin A. Williams;Tatiana Travieso;Jerry Chang;Helen Webster;Lauren E. Williamson;James E. Crowe;Harry B. Greenberg;Huali Wu;Christoph P. Hornik;Katayoun Mansouri;Robert J. Edwards;Victoria Stalls;Priyamvada Acharya;Maria Blasi;Sallie R. Permar - 通讯作者:
Sallie R. Permar
Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
用于解决影响全球健康的传染病的纳米材料疫苗策略的进展
- DOI:
10.1038/s41565-020-0739-9 - 发表时间:
2020-08-17 - 期刊:
- 影响因子:34.900
- 作者:
Chelsea N. Fries;Elizabeth J. Curvino;Jui-Lin Chen;Sallie R. Permar;Genevieve G. Fouda;Joel H. Collier - 通讯作者:
Joel H. Collier
Sallie R. Permar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sallie R. Permar', 18)}}的其他基金
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
原发性母体感染后预防先天性巨细胞病毒传播的免疫相关性的识别和建模
- 批准号:
10677439 - 财政年份:2023
- 资助金额:
$ 0.19万 - 项目类别:
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
母体血浆广泛中和抗体的逃逸是艾滋病毒母婴传播的机制
- 批准号:
10327003 - 财政年份:2021
- 资助金额:
$ 0.19万 - 项目类别:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
SARS-CoV-2 稳定预灌注 Spike 蛋白疫苗在幼年恒河猴中的免疫原性和功效
- 批准号:
10223633 - 财政年份:2020
- 资助金额:
$ 0.19万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 0.19万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 0.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 0.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 0.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
Studentship